Sequenom acquires Michigan CLIA-lab

San Diego, USA-based genomics firm Sequenom has completed its acquisition of a clinical diagnostics laboratory in Grand Rapids, Michigan, USA.

As part of the acquisition, the firm has finalized collaborative agreements with the former joint venture partners in the facility: Spectrum Health, one of Michigan's largest not-for-profit health systems, which annually serves hundreds of thousands of patients at more than 140 service sites including facilitating approximately 8,000 births; and the Van Andel Research Institute, which offers translational research and bioinformatics expertise with the latest in genomics and proteomics technology and is focused primarily on technology development, women's health and oncology.

The renamed Sequenom Center for Molecular Medicine is an advanced molecular pathology laboratory created specifically to support cutting-edge diagnostics, translational research and clinical trials. The facility provides access to robotic DNA and RNA extraction, DNA microarrays, multiplex protein detection, gene expression profiling and other diagnostic services.